Published in Medical Device Business Week, November 3rd, 2004
The receipt of this $250,000 escrowed amount, combined with the recent receipt of approximately $10,000 from the final working capital adjustment settlement, finalizes all open items regarding the sale of ANIP. The ANIP sale is now reported in the company's consolidated financial statements as a discontinued operation and will no longer affect the company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.